The TriGUARD 3™ Cerebral Embolic Protection Device is designed to cover and protect all three major cerebral aortic arch vessels during Transcatheter Aortic Valve Replacement (TAVR) procedures.
TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,July 29, 2020Read More
TAMPA, Fla., June 16, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care,June 16, 2020Read More
Merger Establishes US and EMEA Presence for the Preeminent Chinese Structural Heart Company HANGZHOU, China and CAESAREA, Israel and TAMPA, FloridaJanuary 09, 2019Read More
Keystone Heart TriGUARD Data Review Jeffrey Moses Conclusions: Overt and Covert stroke are significant complications of TAVR which may be oDecember 03, 2018Read More
Tamim Nazif Conclusions: TriGUARD 3™ offers complete 3 vessel cerebral embolic protection for TAVR Specific design improvements optimizeDecember 03, 2018Read More